Advantages of assaying telomerase activity in ascites for diagnosis of digestive tract malignancies

World Journal of Gastroenterology

Volumn 10, Issue 17, 2004, Pages 2468-2471

  Li, Chung Pin ^a   Huang, Tze Sing ^b   Chao, Yee ^c   Chang, Full Young ^a   Whang Peng, Jacquline ^b   Lee, Shou Dong ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; TELOMERASE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ASCITES; ASCITES CELL; CELL LEVEL; CONTROLLED STUDY; CYTOPATHOLOGY; DENSITOMETRY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DIGESTIVE SYSTEM CANCER; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; GASTROINTESTINAL CARCINOMA; GENDER; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; ASCITES FLUID; CLINICAL TRIAL; GASTROINTESTINAL TUMOR; LIVER TUMOR; METABOLISM; MIDDLE AGED; PROSPECTIVE STUDY;

AGED; ASCITES; ASCITIC FLUID; CARCINOMA, HEPATOCELLULAR; DIAGNOSIS, DIFFERENTIAL; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TELOMERASE;

EID: 4444251434     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i17.2468     Document Type: Article

References (35)

1. Parsons SL, Watson SA, Steele RJ. Malignant ascites. Br J Surg 1996; 83: 6-14
2. Tang ZY. Hepatocellular carcinoma-cause, treatment and metastasis. World J Gastroenterol 2001; 7: 445-454
3. Runyon BA. Care of patients with ascites. N Engl J Med 1994; 330: 337-342
4. Blackburn EH. Structure and function of telomeres. Nature 1991; 350: 569-573
5. Shay JW. Telomerase in human development and cancer. J Cell Physiol 1997; 173: 266-270
6. Wright WE, Piatyszek MA, Rainey WE, Byrd W, Shay JW. Telomerase activity in human germline and embryonic tissues and cells. Dev Genet 1996; 18: 173-179
7. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011-2015
8. Shay JW, Wright WE. Telomerase activity in human cancer. Curr Opin Oncol 1996; 8: 66-71
9. Shay JW, Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer 1997; 33: 787-791
10. Yakoob J, Hu GL, Fan XG, Zhang Z. Telomere, telomerase and digestive cancer. World J Gastroenterol 1999; 5: 334-337
11. Toshima S, Arai T, Yasuda Y, Takaya T, Ito Y, Hayakawa K, Shibuya C, Yoshimi N, Shibayama M, Kashiki Y. Cytological diagnosis and telomerase activity of cells in effusions of body cavities. Oncol Rep 1999; 6: 199-203
12. Tangkijvanich P, Tresukosol D, Sampatanukul P, Sakdikul S, Voravud N, Mahachai V, Mutirangura A. Telomerase assay for differentiating between malignancy-related and nonmalignant ascites. Clin Cancer Res 1999; 5: 2470-2475
13. Braunschweig R, Yan P, Guilleret I, Delacretaz F, Bosman FT, Mihaescu A, Benhattar J. Detection of malignant effusions: comparison of a telomerase assay and cytologic examination. Diagn Cytopathol 2001; 24: 174-180
14. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl 1968; 97: 77-89
15. Lee CC, Huang TS. A novel topoisomerase II poison GL331 preferentially induces DNA cleavage at (C/G)T sites and can cause telomere DNA damage. Pharm Res 2001; 18: 846-851
16. Ehya H. Effusion cytology. Clin Lab Med 1991; 11: 443-467
17. Duggan BD, Wan M, Yu MC, Roman LD, Muderspach LI, Delgadillo E, Li WZ, Martin SE, Dubeau L. Detection of ovarian cancer cells: comparison of a telomerase assay and cytologic examination. J Natl Cancer Inst 1998; 90: 238-242
18. Kim NW. Clinical implications of telomerase in cancer. Eur J Cancer 1997; 33: 781-786
19. Gelmini S, Caldini A, Becherini L, Capaccioli S, Pazzagli M, Orlando C. Rapid, quantitative nonisotopic assay for telomerase activity in human tumors. Clin Chem 1998; 44: 2133-2138
20. Falconieri G, Zanconati F, Colautti I, Dudine S, Bonifacio-Gori D, Di Bonito L. Effusion cytology of hepatocellular carcinoma. Acta Cytol 1995; 39: 893-897
21. Colli A, Cocciolo M, Riva C, Marcassoli L, Pirola M, Di Gregorio P, Buccino G. Ascitic fluid analysis in hepatocellular carcinoma. Cancer 1993; 72: 677-682
22. Yuasa S, Itoshima T, Nagashima H. Clinical studies of hepatocellular carcinoma with liver cirrhosis and ascites. Acta Med Okayama 1984; 38: 291-299
23. Runyon BA, Hoefs JC, Morgan TR. Ascitic fluid analysis in malignancy-related ascites. Hepatology 1988; 8: 1104-1109
24. Nakashima T, Okuda K, Kojiro M, Jimi A, Yamaguchi R, Sakamoto K, Ikari T. Pathology of hepatocellular carcinoma in Japan. 232 Consecutive cases autopsied in ten years. Cancer 1983; 51: 863-877
25. Toniatti C, Arcone R, Majello B, Ganter U, Arpaia G, Ciliberto G. Regulation of the human C-reactive protein gene, a major marker of inflammation and cancer. Mol Biol Med 1990; 7: 199-212
26. Mahmoud FA, Rivera NI. The role of C-reactive protein as a prognostic indicator in advanced cancer. Curr Oncol Rep 2002; 4: 250-255
27. Akiba J, Yano H, Ogasawara S, Higaki K, Kojiro M. Expression and function of interleukin-8 in human hepatocellular carcinoma. Int J Oncol 2001; 18: 257-264
28. Chau GY, Wu CW, Lui WY, Chang TJ, Kao HL, Wu LH, King KL, Loong CC, Hsia CY, Chi CW. Serum interleukin-10 but not interleukin-6 is related to clinical outcome in patients with resectable hepatocellular carcinoma. Ann Surg 2000; 231: 552-558
29. Price JA, Kovach SJ, Johnson T, Koniaris LG, Cahill PA, Sitzmann JV, McKillop IH. Insulin-like growth factor I is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma. Hepatology 2002; 36: 1089-1097
30. Su Q, Liu YF, Zhang JF, Zhang SX, Li DF, Yang JJ. Expression of insulin-like growth factor II in hepatitis B, cirrhosis and hepatocellular carcinoma: its relationship with hepatitis B virus antigen expression. Hepatology 1994; 20(4 Pt 1): 788-799
31. Akiyama M, Hideshima T, Hayashi T, Tai YT, Mitsiades CS, Mitsiades N, Chauhan D, Richardson P, Munshi NC, Anderson KC. Cytokines modulate telomerase activity in a human multiple myeloma cell line. Cancer Res 2002; 62: 3876-3882
32. Wilson J, Balkwill F. The role of cytokines in the epithelial cancer microenvironment. Semin Cancer Biol 2002; 12: 113-120
33. Counter CM, Gupta J, Harley CB, Leber B, Bacchetti S. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 1995; 85: 2315-2320
34. Hiyama K, Hirai Y, Kyoizumi S, Akiyama M, Hiyama E, Piatyszek MA, Shay JW, Ishioka S, Yamakido M. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995; 155: 3711-3715
35. Weng NP, Levine BL, June CH, Hodes RJ. Regulated expression of telomerase activity in human T lymphocyte development and activation. J Exp Med 1996; 183: 2471-2479